CG Structure · 2025
In this section9 topics
- Board Composition7 items
- Board of Directors1 item
- Board Meetings & Remuneration1 item
- Audit Committee1 item
- Other Subcommittees1 item
- Executives1 item
- Auditors and Audit Fees1 item
- Company Secretary and Other Assigned Persons4 items
- Investor Relations Contact1 item
Board Composition
Total Number of Directors
11
Male Directors
7
Female Directors
4
Independent Directors
5
Non-executive Directors
6
Executive Directors
5
Total Board Meetings Held
10
Board of Directors
Directors
| First Name | Last Name | Gender | Year of Birth | Resident in Thailand? | Position | Executive or Non-executive | Independent Director? | Director Type | Appointment Date | Skills & Expertise | Attended Director Training? | Board Meetings Held | Board Meetings Attended | Meeting Allowance (Baht) | Other Remuneration (Baht) | Non-monetary Remuneration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| THONGCHAI | THAVICHACHART | M | 1,949 | Y | 32 · Description: Chairman of the board | 31 · Description: Non-executive | Y | 41 · Description: Re-elected as director | 2020-07-21 | 134 · Description: Health Care Services · 158 · Description: Corporate Management · 163 · Description: Leadership · 164 · Description: Strategic Management | N | 10 | 10 | 460,000 | 100,000 | N |
| LALITA | HONGRATANAWONG | F | 1,977 | Y | 34 · Description: Director | 31 · Description: Non-executive | Y | 40 · Description: Original director | 2018-12-03 | 143 · Description: Accounting · 144 · Description: Finance · 152 · Description: Data Analysis · 133 · Description: Commerce | Y | 10 | 9 | 135,000 | 100,000 | N |
| VINIT | USAVAKIDVIREE | M | 1,956 | Y | 34 · Description: Director | 31 · Description: Non-executive | Y | 40 · Description: Original director | 2018-12-03 | 134 · Description: Health Care Services · 117 · Description: Personal Products & Pharmaceuticals · 141 · Description: Law · 165 · Description: Risk Management | N | 10 | 10 | 150,000 | 100,000 | N |
| JINTANA | SANTIPISUD | F | 1,955 | Y | 34 · Description: Director | 30 · Description: Executive | 40 · Description: Original director | 2018-12-03 | 142 · Description: Marketing · 1683 · Description: Business Administration | Y | 10 | 10 | 0 | |||
| SITTICHAI | DAENGPRASERT | M | 1,982 | Y | 34 · Description: Director | 30 · Description: Executive | 41 · Description: Re-elected as director | 2018-12-03 | 156 · Description: Negotiation · 158 · Description: Corporate Management · 1683 · Description: Business Administration · 117 · Description: Personal Products & Pharmaceuticals | Y | 10 | 10 | 0 | |||
| PISSANU | DAENGPRASERT | M | 1,982 | Y | 34 · Description: Director | 30 · Description: Executive | 40 · Description: Original director | 2018-12-03 | 114 · Description: Food & Beverage · 155 · Description: Brand Management · 142 · Description: Marketing · 117 · Description: Personal Products & Pharmaceuticals | Y | 10 | 10 | 0 | |||
| JIRADA | DAENGPRASERT | F | 1,984 | Y | 34 · Description: Director | 30 · Description: Executive | 41 · Description: Re-elected as director | 2018-12-03 | 143 · Description: Accounting · 144 · Description: Finance · 146 · Description: Human Resource Management · 165 · Description: Risk Management · 265 · Description: Governance/ Compliance | Y | 10 | 10 | 0 | |||
| SORASIT | DAENGPRASERT | M | 1,986 | Y | 34 · Description: Director | 30 · Description: Executive | 40 · Description: Original director | 2019-02-06 | 151 · Description: Data Management · 165 · Description: Risk Management · 114 · Description: Food & Beverage · 148 · Description: Procurement | Y | 10 | 9 | 0 | |||
| NATTHAWUT | VIBOONPATANAWONG | M | 1,982 | Y | 34 · Description: Director | 31 · Description: Non-executive | Y | 40 · Description: Original director | 2020-03-18 | 157 · Description: Project Management · 165 · Description: Risk Management · 152 · Description: Data Analysis · 159 · Description: Engineering | N | 10 | 7 | 105,000 | 100,000 | N |
| TAWAT | KITKUNGVAN | M | 1,983 | Y | 34 · Description: Director | 31 · Description: Non-executive | N | 40 · Description: Original director | 2020-03-18 | 149 · Description: Fund Management · 165 · Description: Risk Management · 133 · Description: Commerce · 144 · Description: Finance · 157 · Description: Project Management | N | 10 | 4 | 60,000 | 100,000 | N |
| SOPAWADEE | LERTMANASCHAI | F | 1,953 | Y | 34 · Description: Director | 31 · Description: Non-executive | Y | 40 · Description: Original director | 2021-03-24 | 143 · Description: Accounting · 141 · Description: Law · 144 · Description: Finance · 166 · Description: Audit · 265 · Description: Governance/ Compliance | Y | 10 | 9 | 135,000 | 100,000 | N |
Board Meetings & Remuneration
Date of the Annual General Meeting
2025-04-22
Audit Committee
Audit Committee Members
| First Name | Last Name | Position | Gender | Year of Birth | Resident in Thailand? | Appointment Date | Skills & Expertise | Meetings Held | Meetings Attended |
|---|---|---|---|---|---|---|---|---|---|
| SOPAWADEE | LERTMANASCHAI | 35 · Description: Chairman of the audit committee | F | 1,953 | Y | 2021-03-24 | 143 · Description: Accounting · 141 · Description: Law · 144 · Description: Finance · 166 · Description: Audit · 265 · Description: Governance/ Compliance | 5 | 5 |
| LALITA | HONGRATANAWONG | 36 · Description: Audit committee | F | 1,977 | Y | 2018-12-03 | 143 · Description: Accounting · 144 · Description: Finance · 152 · Description: Data Analysis · 133 · Description: Commerce | 5 | 5 |
| VINIT | USAVAKIDVIREE | 36 · Description: Audit committee | M | 1,956 | Y | 2018-12-03 | 134 · Description: Health Care Services · 117 · Description: Personal Products & Pharmaceuticals · 141 · Description: Law · 165 · Description: Risk Management | 5 | 5 |
Other Subcommittees
Other Subcommittees
Executives
Executives
| First Name | Last Name | Position | Gender | Year of Birth | Appointment Date | Skills & Expertise | Is the Highest-ranking Accounting or Finance Officer? | Directly Responsible for Accounting? |
|---|---|---|---|---|---|---|---|---|
| SITTICHAI | DAENGPRASERT | President | M | 1,982 | 2018-12-03 | 156 · Description: Negotiation · 158 · Description: Corporate Management · 1683 · Description: Business Administration · 117 · Description: Personal Products & Pharmaceuticals | N | N |
| PISSANU | DAENGPRASERT | Executive Vice President of Sales and Marketing | M | 1,982 | 2018-12-03 | 114 · Description: Food & Beverage · 155 · Description: Brand Management · 142 · Description: Marketing · 117 · Description: Personal Products & Pharmaceuticals | N | N |
| JIRADA | DAENGPRASERT | Executive Vice President of Finance and Accounting | F | 1,984 | 2018-12-03 | 143 · Description: Accounting · 144 · Description: Finance · 146 · Description: Human Resource Management · 165 · Description: Risk Management · 265 · Description: Governance/ Compliance | Y | N |
| SORASIT | DAENGPRASERT | Executive Vice President of Manufacturing and Operations | M | 1,986 | 2018-12-03 | 151 · Description: Data Management · 165 · Description: Risk Management · 114 · Description: Food & Beverage · 148 · Description: Procurement | N | N |
| Poonsap | Ruangsri | Vice President of Accounting | F | 1,966 | 2015-11-02 | 143 · Description: Accounting | N | Y |
| KRIANGKRAI | RUNGRUANGTHAWEEKUL | Vice President of Finance | M | 1,985 | 2018-12-03 | 143 · Description: Accounting · 144 · Description: Finance · 152 · Description: Data Analysis · 166 · Description: Audit | N | N |
| NONGNUCH | CHEAWPATTAYAKORN | QA and QC Director | F | 1,977 | 2021-01-18 | 117 · Description: Personal Products & Pharmaceuticals · 153 · Description: Statistics · 167 · Description: Internal Control | N | N |
| DANAISUAN | KUNAROJANASOMBHAT | Plant Director | M | 1,981 | 2021-01-18 | 114 · Description: Food & Beverage · 117 · Description: Personal Products & Pharmaceuticals · 159 · Description: Engineering | N | N |
Auditors and Audit Fees
Company Auditor and Fees
| Audit Fee (Baht) |
|---|
| 5,850,000 |
Company Secretary and Other Assigned Persons
Company Secretary
| First Name | Last Name | Telephone | |
|---|---|---|---|
| JIRADA | DAENGPRASERT | jspcs@jsppharma.com | 022841218 |
Chief Accountant
| First Name | Last Name | Telephone | |
|---|---|---|---|
| POONSAP | RUANGSRI | vpaccounting.af@jsppharma.com | 022841218 |
Head of Internal Audit
| First Name | Last Name | |
|---|---|---|
| SIRISAK | MANITKUNAKARN | bee.isbar@gmail.com |
Head of Compliance
| First Name | Last Name | Telephone | |
|---|---|---|---|
| KRIANGKRAI | RUNGRUANGTHAWEEKUL | vp.af@jsppharma.com | 022841218 |
Investor Relations Contact
Investor Relations Contacts
| First Name | Last Name | Telephone | |
|---|---|---|---|
| KRIANGKRAI | RUNGRUANGTHAWEEKUL | ir@jsppharma.com | 022841218 |

